HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel M Ramos Selected Research

integrin beta6

1/2009The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
3/2005The expression of integrin alpha(v)beta6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes.
4/2004Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix.
10/2003Alphavbeta6-Fyn signaling promotes oral cancer progression.
6/2002Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel M Ramos Research Topics

Disease

10Neoplasms (Cancer)
02/2014 - 04/2002
6Mouth Neoplasms (Oral Cancer)
04/2011 - 10/2003
5Squamous Cell Carcinoma of Head and Neck
11/2013 - 04/2002
3Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2021 - 01/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009 - 06/2002
3Neoplasm Metastasis (Metastasis)
04/2004 - 04/2002
2Melanoma (Melanoma, Malignant)
02/2006 - 09/2003
1Neuromuscular Diseases (Neuromuscular Disease)
01/2021
1Muscular Atrophy (Muscle Atrophy)
11/2019
1Neurilemmoma (Schwannoma)
09/2008
1Pleomorphic Adenoma
02/2005
1Adenoid Cystic Carcinoma (Cylindroma)
02/2005
1Salivary Gland Neoplasms (Salivary Gland Cancer)
02/2005
1Adenocarcinoma
02/2005
1Warts (Wart)
12/2002
1Carcinoma (Carcinomatosis)
06/2002

Drug/Important Bio-Agent (IBA)

6IntegrinsIBA
02/2014 - 04/2002
5Proteins (Proteins, Gene)FDA Link
11/2019 - 06/2002
5integrin beta6IBA
01/2009 - 06/2002
3Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
11/2013 - 07/2008
3TenascinIBA
02/2005 - 06/2002
2RNA Precursors (Precursor, mRNA)IBA
01/2021 - 12/2020
2Integrin alphaVIBA
01/2009 - 09/2003
2Matrix Metalloproteinases (MMPs)IBA
07/2008 - 04/2004
2Formaldehyde (Formol)FDA Link
02/2005 - 06/2002
1LigandsIBA
04/2011
1Phosphotransferases (Kinase)IBA
07/2010
1ErbB Receptors (EGF Receptor)IBA
12/2009
1AntibodiesIBA
06/2009
1VimentinIBA
01/2009
1Cadherins (E-Cadherin)IBA
01/2009
1Keratins (Keratin)IBA
01/2009
1CarcinogensIBA
07/2008
1Integrin alphaVbeta3IBA
02/2006
1Metalloproteases (Metalloproteinases)IBA
02/2006
1Actin Depolymerizing Factors (Cofilins)IBA
02/2006
1VitronectinIBA
02/2006
1ParaffinIBA
02/2005
1Messenger RNA (mRNA)IBA
12/2002
1AntigensIBA
12/2002
1methyl N-acetylsibirosaminide (MASA)IBA
09/2002
1Codon (Codons)IBA
09/2002
1Biological ProductsIBA
06/2002
1Fibronectins (Fibronectin)IBA
04/2002
1integrin alphavbeta6IBA
04/2002

Therapy/Procedure

1Therapeutics
01/2021
1Eye Enucleation (Enucleation, Eye)
09/2008